NCT07426055 2026-02-23
PRO-BOOST-LC
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Not yet recruiting
Clinical Trials
9 trialsNCT06977061 2025-05-16
Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression
Second Affiliated Hospital of Nanchang University
Phase 2/3 Not yet recruiting
NCT02685397 2024-12-04
PCS IX
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2/3 Active not recruiting
NCT06185556 2024-08-23
COLDFIRE-III
Amsterdam UMC, location VUmc
Phase 2/3 Recruiting
NCT03256981 2023-12-26
HALT
Institute of Cancer Research, United Kingdom
Phase 2/3 Unknown
NCT04654338 2023-06-27
EARTH
Sunnybrook Health Sciences Centre
Phase 2/3 Recruiting
NCT05181605 2022-08-09
Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors
Instituto de investigación e innovación biomédica de Cádiz
Phase 2/3 Unknown
NCT04167293 2021-03-23
ISBRT01
Sun Yat-sen University
Phase 2/3 Unknown
NCT02759783 2019-08-21
CORE
Royal Marsden NHS Foundation Trust
Phase 2/3 Unknown